_id
69185dfa3c536f8df2317d63
Ticker
0QW0.LSE
Name
Argen-X
Exchange
LSE
Address
Laarderhoogtweg 25, Amsterdam, Netherlands, 1101 EB
Country
UK
Sector
Industry
Currency
EUR
Website
https://argenx.com
Description
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Last Close
357.04132
Volume
2121
Current Price
698.6207
Change
-1.355955103459733
Last Updated
2025-12-05T15:04:25.133Z
Image
https://logo.clearbit.com/argenx.com
Ipo Date
-
Market Cap
13373915136
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
1303249599
Cost Of Revenue
641824108
Gross Profit
661425491
Operating Expenses
548265303
Operating Income
113160188
Interest Expense
1976048
Pretax Income
168476704
Net Income
835535686
Eps
11.775503103618043
Dividends Per Share
-
Shares Outstanding
32450800
Income Tax Expense
-638368762
EBITDA
125935933
Operating Margin
8.68292521147363
Total Other Income Expense Net
55316516
Cash
1447888220
Short Term Investments
1813692517
Receivables
873085856
Inventories
393102014
Total Current Assets
4713659325
Property Plant Equipment
42006960
Total Assets
5987294486
Payables
627438242
Short Term Debt
6306304
Long Term Debt
-
Total Liabilities
679801907
Equity
5307492579
Depreciation
8595031
Change In Working Capital
-380197885
Cash From Operations
40454757
Capital Expenditures
955647
Cash From Investing
-196761925
Cash From Financing
231367930
Net Change In Cash
-1342603574
PE
-
PB
9.339800209045022
ROE
15.742569086312802
ROA
13.955145983778156
FCF
39499110
Fcf Percent
0.03030816969390067
Piotroski FScore
3
Health Score
62
Deep Value Investing Score
7.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
10
Garp Investing Score
9.5
Growth Investing Score
7.5
Momentum Investing Score
3
Net Net Investing Score
4
Quality Investing Score
9
Value Investing Score
7
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
1303249599
Quarters > 0 > income Statement > cost Of Revenue
641824108
Quarters > 0 > income Statement > gross Profit
661425491
Quarters > 0 > income Statement > operating Expenses
548265303
Quarters > 0 > income Statement > operating Income
113160188
Quarters > 0 > income Statement > interest Expense
1976048
Quarters > 0 > income Statement > pretax Income
168476704
Quarters > 0 > income Statement > net Income
835535686
Quarters > 0 > income Statement > eps
11.775503103618043
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
70955413
Quarters > 0 > income Statement > income Tax Expense
-638368762
Quarters > 0 > income Statement > EBITDA
125935933
Quarters > 0 > income Statement > operating Margin
8.68292521147363
Quarters > 0 > income Statement > total Other Income Expense Net
55316516
Quarters > 0 > balance Sheet > cash
1447888220
Quarters > 0 > balance Sheet > short Term Investments
1813692517
Quarters > 0 > balance Sheet > receivables
873085856
Quarters > 0 > balance Sheet > inventories
393102014
Quarters > 0 > balance Sheet > total Current Assets
4713659325
Quarters > 0 > balance Sheet > property Plant Equipment
42006960
Quarters > 0 > balance Sheet > total Assets
5987294486
Quarters > 0 > balance Sheet > payables
627438242
Quarters > 0 > balance Sheet > short Term Debt
6306304
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
679801907
Quarters > 0 > balance Sheet > equity
5307492579
Quarters > 0 > cash Flow > net Income
835535686
Quarters > 0 > cash Flow > depreciation
8595031
Quarters > 0 > cash Flow > change In Working Capital
-380197885
Quarters > 0 > cash Flow > cash From Operations
40454757
Quarters > 0 > cash Flow > capital Expenditures
955647
Quarters > 0 > cash Flow > cash From Investing
-196761925
Quarters > 0 > cash Flow > cash From Financing
231367930
Quarters > 0 > cash Flow > net Change In Cash
-1342603574
Quarters > 0 > ratios > PE
11.775503103618043
Quarters > 0 > ratios > PB
9.339800209045022
Quarters > 0 > ratios > ROE
15.742569086312802
Quarters > 0 > ratios > ROA
13.955145983778156
Quarters > 0 > ratios > FCF
39499110
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.03030816969390067
Quarters > 0 > health Score
62
Quarters > 1 > quarter
2024-09-30
Quarters > 1 > income Statement > revenue
573236000
Quarters > 1 > income Statement > cost Of Revenue
59072000
Quarters > 1 > income Statement > gross Profit
514164000
Quarters > 1 > income Statement > operating Expenses
499977000
Quarters > 1 > income Statement > operating Income
14187000
Quarters > 1 > income Statement > interest Expense
676000
Quarters > 1 > income Statement > pretax Income
88024000
Quarters > 1 > income Statement > net Income
91410000
Quarters > 1 > income Statement > eps
1.3899999984793787
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
65762590
Quarters > 1 > income Statement > income Tax Expense
-3386000
Quarters > 1 > income Statement > EBITDA
88700000
Quarters > 1 > income Statement > operating Margin
2.474896901101815
Quarters > 1 > income Statement > total Other Income Expense Net
73837000
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > cash Flow > net Income
84170330
Quarters > 1 > cash Flow > depreciation
74513000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > ratios > PE
1.3899999984793787
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
54
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
841961923
Quarters > 2 > income Statement > cost Of Revenue
509519236
Quarters > 2 > income Statement > gross Profit
332442687
Quarters > 2 > income Statement > operating Expenses
462089033
Quarters > 2 > income Statement > operating Income
-129646346
Quarters > 2 > income Statement > interest Expense
365254
Quarters > 2 > income Statement > pretax Income
-83411025
Quarters > 2 > income Statement > net Income
-30367688
Quarters > 2 > income Statement > eps
-0.5112386710641141
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
59400217
Quarters > 2 > income Statement > income Tax Expense
-52571212
Quarters > 2 > income Statement > EBITDA
-118504091
Quarters > 2 > income Statement > operating Margin
-15.398124601413835
Quarters > 2 > income Statement > total Other Income Expense Net
46235321
Quarters > 2 > balance Sheet > cash
1438247000
Quarters > 2 > balance Sheet > short Term Investments
1664100000
Quarters > 2 > balance Sheet > receivables
655561000
Quarters > 2 > balance Sheet > inventories
326460000
Quarters > 2 > balance Sheet > total Current Assets
4263788000
Quarters > 2 > balance Sheet > property Plant Equipment
36931000
Quarters > 2 > balance Sheet > total Assets
4796558000
Quarters > 2 > balance Sheet > payables
280633000
Quarters > 2 > balance Sheet > short Term Debt
5853000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
534311000
Quarters > 2 > balance Sheet > equity
4262247000
Quarters > 2 > cash Flow > net Income
-30367688
Quarters > 2 > cash Flow > depreciation
7977923
Quarters > 2 > cash Flow > change In Working Capital
-165830674
Quarters > 2 > cash Flow > cash From Operations
-116366376
Quarters > 2 > cash Flow > capital Expenditures
757068
Quarters > 2 > cash Flow > cash From Investing
-479594026
Quarters > 2 > cash Flow > cash From Financing
37409079
Quarters > 2 > cash Flow > net Change In Cash
1342603574
Quarters > 2 > ratios > PE
-0.5112386710641141
Quarters > 2 > ratios > PB
9.736230955336916
Quarters > 2 > ratios > ROE
-0.7124807173305536
Quarters > 2 > ratios > ROA
-0.6331141622805353
Quarters > 2 > ratios > FCF
-117123444
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.13910776817872797
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
401001000
Quarters > 3 > income Statement > cost Of Revenue
43178000
Quarters > 3 > income Statement > gross Profit
357823000
Quarters > 3 > income Statement > operating Expenses
449452000
Quarters > 3 > income Statement > operating Income
-93421000
Quarters > 3 > income Statement > interest Expense
512000
Quarters > 3 > income Statement > pretax Income
-74350000
Quarters > 3 > income Statement > net Income
-61597000
Quarters > 3 > income Statement > eps
-1.0385601779504419
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
59309996
Quarters > 3 > income Statement > income Tax Expense
-12753000
Quarters > 3 > income Statement > EBITDA
-54526000
Quarters > 3 > income Statement > operating Margin
-23.296949384166123
Quarters > 3 > income Statement > total Other Income Expense Net
19071000
Quarters > 3 > balance Sheet > cash
-2946761434
Quarters > 3 > balance Sheet > short Term Investments
5893522868
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2946761434
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
3797159736
Quarters > 3 > cash Flow > net Income
-61597000
Quarters > 3 > cash Flow > depreciation
24053194
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > ratios > PE
-1.0385601779504419
Quarters > 3 > ratios > PB
10.912153768428455
Quarters > 3 > ratios > ROE
-1.6221861676245268
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2173893246
Annuals > 0 > income Statement > cost Of Revenue
1168700293
Annuals > 0 > income Statement > gross Profit
1005192953
Annuals > 0 > income Statement > operating Expenses
1026095559
Annuals > 0 > income Statement > operating Income
-20902606
Annuals > 0 > income Statement > interest Expense
4051232
Annuals > 0 > income Statement > pretax Income
82224254
Annuals > 0 > income Statement > net Income
804133512
Annuals > 0 > income Statement > eps
12.337534241329418
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
65177814
Annuals > 0 > income Statement > income Tax Expense
-691380596
Annuals > 0 > income Statement > EBITDA
3394960
Annuals > 0 > income Statement > operating Margin
-0.9615286324874115
Annuals > 0 > income Statement > total Other Income Expense Net
103126860
Annuals > 0 > balance Sheet > cash
1447888220
Annuals > 0 > balance Sheet > short Term Investments
1813692517
Annuals > 0 > balance Sheet > receivables
873085856
Annuals > 0 > balance Sheet > inventories
393102014
Annuals > 0 > balance Sheet > total Current Assets
4713659325
Annuals > 0 > balance Sheet > property Plant Equipment
42006960
Annuals > 0 > balance Sheet > total Assets
5987294486
Annuals > 0 > balance Sheet > payables
627438242
Annuals > 0 > balance Sheet > short Term Debt
6306304
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
679801907
Annuals > 0 > balance Sheet > equity
5307492579
Annuals > 0 > cash Flow > net Income
804133512
Annuals > 0 > cash Flow > depreciation
16918813
Annuals > 0 > cash Flow > change In Working Capital
-551677636
Annuals > 0 > cash Flow > cash From Operations
-79875679
Annuals > 0 > cash Flow > capital Expenditures
1738505
Annuals > 0 > cash Flow > cash From Investing
-692693488
Annuals > 0 > cash Flow > cash From Financing
270051362
Annuals > 0 > cash Flow > net Change In Cash
-407954675
Annuals > 0 > ratios > PE
12.337534241329418
Annuals > 0 > ratios > PB
9.719889196853082
Annuals > 0 > ratios > ROE
15.150911659899279
Annuals > 0 > ratios > ROA
13.43066578536087
Annuals > 0 > ratios > FCF
-81614184
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.037542866536878695
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1226316000
Annuals > 1 > income Statement > cost Of Revenue
117835000
Annuals > 1 > income Statement > gross Profit
1108481000
Annuals > 1 > income Statement > operating Expenses
1533530000
Annuals > 1 > income Statement > operating Income
-425049000
Annuals > 1 > income Statement > interest Expense
904000
Annuals > 1 > income Statement > pretax Income
-304496000
Annuals > 1 > income Statement > net Income
-295053000
Annuals > 1 > income Statement > eps
-5.161043472091546
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
57169253
Annuals > 1 > income Statement > income Tax Expense
-9443000
Annuals > 1 > income Statement > EBITDA
-192285000
Annuals > 1 > income Statement > operating Margin
-34.660642118344704
Annuals > 1 > income Statement > total Other Income Expense Net
120553000
Annuals > 1 > balance Sheet > cash
2048844000
Annuals > 1 > balance Sheet > short Term Investments
1131000000
Annuals > 1 > balance Sheet > receivables
499271000
Annuals > 1 > balance Sheet > inventories
310550000
Annuals > 1 > balance Sheet > total Current Assets
4123737000
Annuals > 1 > balance Sheet > property Plant Equipment
22676000
Annuals > 1 > balance Sheet > total Assets
4542458000
Annuals > 1 > balance Sheet > payables
245557000
Annuals > 1 > balance Sheet > short Term Debt
4646000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
444951000
Annuals > 1 > balance Sheet > equity
4097507000
Annuals > 1 > cash Flow > net Income
-425049000
Annuals > 1 > cash Flow > depreciation
111307000
Annuals > 1 > cash Flow > change In Working Capital
-308891000
Annuals > 1 > cash Flow > cash From Operations
-420327000
Annuals > 1 > cash Flow > capital Expenditures
43812000
Annuals > 1 > cash Flow > cash From Investing
308210000
Annuals > 1 > cash Flow > cash From Financing
1336727000
Annuals > 1 > cash Flow > net Change In Cash
1248104000
Annuals > 1 > ratios > PE
-5.161043472091546
Annuals > 1 > ratios > PB
11.043169358710063
Annuals > 1 > ratios > ROE
-7.200793067589635
Annuals > 1 > ratios > ROA
-6.495448059178532
Annuals > 1 > ratios > FCF
-464139000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.3784823813764152
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
410747000
Annuals > 2 > income Statement > cost Of Revenue
29431000
Annuals > 2 > income Statement > gross Profit
381316000
Annuals > 2 > income Statement > operating Expenses
1101657000
Annuals > 2 > income Statement > operating Income
-720341000
Annuals > 2 > income Statement > interest Expense
2193000
Annuals > 2 > income Statement > pretax Income
-729314000
Annuals > 2 > income Statement > net Income
-709594000
Annuals > 2 > income Statement > eps
-13.0484757362958
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
54381371
Annuals > 2 > income Statement > income Tax Expense
-19720000
Annuals > 2 > income Statement > EBITDA
-622779000
Annuals > 2 > income Statement > operating Margin
-175.3734050400855
Annuals > 2 > income Statement > total Other Income Expense Net
-8973000
Annuals > 2 > balance Sheet > cash
800740000
Annuals > 2 > balance Sheet > short Term Investments
1391808000
Annuals > 2 > balance Sheet > receivables
277275000
Annuals > 2 > balance Sheet > inventories
228353000
Annuals > 2 > balance Sheet > total Current Assets
2774197000
Annuals > 2 > balance Sheet > property Plant Equipment
16235000
Annuals > 2 > balance Sheet > total Assets
3134261000
Annuals > 2 > balance Sheet > payables
188721000
Annuals > 2 > balance Sheet > short Term Debt
3417000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
320562000
Annuals > 2 > balance Sheet > equity
2813699000
Annuals > 2 > cash Flow > net Income
-720341000
Annuals > 2 > cash Flow > depreciation
104342000
Annuals > 2 > cash Flow > change In Working Capital
-375722000
Annuals > 2 > cash Flow > cash From Operations
-862807000
Annuals > 2 > cash Flow > capital Expenditures
103823000
Annuals > 2 > cash Flow > cash From Investing
-461184000
Annuals > 2 > cash Flow > cash From Financing
843757000
Annuals > 2 > cash Flow > net Change In Cash
-533936000
Annuals > 2 > ratios > PE
-13.0484757362958
Annuals > 2 > ratios > PB
15.297604735439007
Annuals > 2 > ratios > ROE
-25.21925763914335
Annuals > 2 > ratios > ROA
-22.639914161583864
Annuals > 2 > ratios > FCF
-966630000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-2.3533464638816595
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
497277000
Annuals > 3 > income Statement > cost Of Revenue
510044872
Annuals > 3 > income Statement > gross Profit
497277000
Annuals > 3 > income Statement > operating Expenses
846023000
Annuals > 3 > income Statement > operating Income
-348746000
Annuals > 3 > income Statement > interest Expense
1096000
Annuals > 3 > income Statement > pretax Income
-399743000
Annuals > 3 > income Statement > net Income
-408265000
Annuals > 3 > income Statement > eps
-7.739485870578181
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
52750920
Annuals > 3 > income Statement > income Tax Expense
8522000
Annuals > 3 > income Statement > EBITDA
-392780000
Annuals > 3 > income Statement > operating Margin
-70.13113415661694
Annuals > 3 > income Statement > total Other Income Expense Net
-50997000
Annuals > 3 > balance Sheet > cash
1334676000
Annuals > 3 > balance Sheet > short Term Investments
1002052000
Annuals > 3 > balance Sheet > receivables
38221000
Annuals > 3 > balance Sheet > inventories
109076000
Annuals > 3 > balance Sheet > total Current Assets
2542971000
Annuals > 3 > balance Sheet > property Plant Equipment
15843000
Annuals > 3 > balance Sheet > total Assets
2850274000
Annuals > 3 > balance Sheet > payables
208850000
Annuals > 3 > balance Sheet > short Term Debt
3509000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
316050000
Annuals > 3 > balance Sheet > equity
2534224000
Annuals > 3 > cash Flow > net Income
-348746000
Annuals > 3 > cash Flow > depreciation
4963701
Annuals > 3 > cash Flow > change In Working Capital
-340951000
Annuals > 3 > cash Flow > cash From Operations
-606812000
Annuals > 3 > cash Flow > capital Expenditures
121434000
Annuals > 3 > cash Flow > cash From Investing
-347070000
Annuals > 3 > cash Flow > cash From Financing
1121342000
Annuals > 3 > cash Flow > net Change In Cash
117873000
Annuals > 3 > ratios > PE
-7.739485870578181
Annuals > 3 > ratios > PB
16.47539964107356
Annuals > 3 > ratios > ROE
-16.110059726369887
Annuals > 3 > ratios > ROA
-14.323710632732151
Annuals > 3 > ratios > FCF
-728246000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.4644674899502692
Annuals > 3 > health Score
27
Valuation > metrics > PE
11.775503103618043
Valuation > metrics > PB
9.339800209045022
Valuation > final Score
50
Valuation > verdict
105.7% Overvalued
Profitability > metrics > ROE
15.742569086312802
Profitability > metrics > ROA
17.72583948883493
Profitability > metrics > Net Margin
0.6411171633132419
Profitability > final Score
91
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.12808343994483426
Risk > metrics > Interest Coverage
57.26591054468312
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
7.437790754573216
Liquidity > metrics > Quick Ratio
6.817506104423343
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
59
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
70
Prev Risks > 1
-1360
Prev Risks > 2
-670
Prev Liquidities > 0
50
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-22T21:20:09.009Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
3.83
Earnings History > 0 > eps Difference
-3.83
Earnings History > 0 > surprise Percent
-100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-30
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
4.48
Earnings History > 1 > eps Estimate
4.3
Earnings History > 1 > eps Difference
0.18
Earnings History > 1 > surprise Percent
4.186
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-31
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
3.27
Earnings History > 2 > eps Estimate
2.76
Earnings History > 2 > eps Difference
0.51
Earnings History > 2 > surprise Percent
18.4783
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-08
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
2.29
Earnings History > 3 > eps Estimate
2.11
Earnings History > 3 > eps Difference
0.18
Earnings History > 3 > surprise Percent
8.5308
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
11.32
Earnings History > 4 > eps Estimate
1.65
Earnings History > 4 > eps Difference
9.67
Earnings History > 4 > surprise Percent
586.0606
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-31
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
1.28
Earnings History > 5 > eps Estimate
0.1266
Earnings History > 5 > eps Difference
1.1534
Earnings History > 5 > surprise Percent
911.0585
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-07-25
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.4145
Earnings History > 6 > eps Estimate
0.41
Earnings History > 6 > eps Difference
0.0045
Earnings History > 6 > surprise Percent
1.0976
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.9651
Earnings History > 7 > eps Estimate
-0.7272
Earnings History > 7 > eps Difference
-0.2379
Earnings History > 7 > surprise Percent
-32.7145
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-12
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-1.55
Earnings History > 8 > eps Estimate
-1.19
Earnings History > 8 > eps Difference
-0.36
Earnings History > 8 > surprise Percent
-30.2521
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-10-31
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-1.18
Earnings History > 9 > eps Estimate
-1.18
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-07-27
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-1.54
Earnings History > 10 > eps Estimate
-1.54
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-04
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.4727
Earnings History > 11 > eps Estimate
-0.47
Earnings History > 11 > eps Difference
-0.0027
Earnings History > 11 > surprise Percent
-0.5745
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-02
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.6597
Earnings History > 12 > eps Estimate
-0.66
Earnings History > 12 > eps Difference
0.0003
Earnings History > 12 > surprise Percent
0.0455
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-10-27
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-4.26
Earnings History > 13 > eps Estimate
-4.26
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-07-28
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-3.75
Earnings History > 14 > eps Estimate
-3.75
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-4.14
Earnings History > 15 > eps Estimate
-4.14
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-03
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-3.99
Earnings History > 16 > eps Estimate
-3.92
Earnings History > 16 > eps Difference
-0.07
Earnings History > 16 > surprise Percent
-1.7857
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-10-28
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-3.76
Earnings History > 17 > eps Estimate
-3.73
Earnings History > 17 > eps Difference
-0.03
Earnings History > 17 > surprise Percent
-0.8043
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-29
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
1.67
Earnings History > 18 > eps Estimate
1.85
Earnings History > 18 > eps Difference
-0.18
Earnings History > 18 > surprise Percent
-9.7297
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-14
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.6676
Earnings History > 19 > eps Estimate
-0.67
Earnings History > 19 > eps Difference
0.0024
Earnings History > 19 > surprise Percent
0.3582
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-04
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-3.49
Earnings History > 20 > eps Estimate
-3.38
Earnings History > 20 > eps Difference
-0.11
Earnings History > 20 > surprise Percent
-3.2544
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-10-22
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-3.34
Earnings History > 21 > eps Estimate
-3.36
Earnings History > 21 > eps Difference
0.02
Earnings History > 21 > surprise Percent
0.5952
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-2.86
Earnings History > 22 > eps Estimate
-2.81
Earnings History > 22 > eps Difference
-0.05
Earnings History > 22 > surprise Percent
-1.7794
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-14
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-1.87
Earnings History > 23 > eps Estimate
-1.87
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
0
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-27
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-2.26
Earnings History > 24 > eps Estimate
-2.22
Earnings History > 24 > eps Difference
-0.04
Earnings History > 24 > surprise Percent
-1.8018
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-10-24
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.65
Earnings History > 25 > eps Estimate
-0.64
Earnings History > 25 > eps Difference
-0.01
Earnings History > 25 > surprise Percent
-1.5625
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-01
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-1.36
Earnings History > 26 > eps Estimate
-1.34
Earnings History > 26 > eps Difference
-0.02
Earnings History > 26 > surprise Percent
-1.4925
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-09
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
0.18
Earnings History > 27 > eps Estimate
0.18
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
0
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-28
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-0.84
Earnings History > 28 > eps Estimate
-0.84
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
0
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-10-25
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-0.48
Earnings History > 29 > eps Estimate
-0.47
Earnings History > 29 > eps Difference
-0.01
Earnings History > 29 > surprise Percent
-2.1277
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-02
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-0.06
Earnings History > 30 > eps Estimate
-0.11
Earnings History > 30 > eps Difference
0.05
Earnings History > 30 > surprise Percent
45.4545
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-09
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.5
Earnings History > 31 > eps Estimate
-0.48
Earnings History > 31 > eps Difference
-0.02
Earnings History > 31 > surprise Percent
-4.1667
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-01
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
-0.41
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.41
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-10-26
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
-
Earnings History > 33 > eps Actual
-0.47
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.47
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-24
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
-
Earnings History > 34 > eps Actual
0.01
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
0.01
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-02
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
-
Earnings History > 35 > eps Actual
-0.39
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-0.39
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-15
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
-
Earnings History > 36 > eps Actual
-0.44
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
-0.44
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-10-27
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
-
Earnings History > 37 > eps Actual
-0.24
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
-0.24
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2015-12-31
Earnings History > 38 > report Date
2015-12-31
Earnings History > 38 > date
2015-12-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
-
Earnings History > 38 > eps Actual
-0.3314
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AarGEN X (0QW0) Gets a Buy from Bank of America Securities The Globe and Mail
Read more →(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Argen-X
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
3.83
Date
2025-09-30
EPS Actual
4.48
EPS Estimate
4.3
EPS Difference
0.18
Surprise Percent
4.186%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2024-12-31)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.